Vivo Capital, LLC

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
40
Total Value
755066478
Accession Number
0001213900-25-041737
Form Type
13F-HR
Manager Name
Vivo-Capital
Data Enrichment
98% identified
39 identified1 unidentified

Holdings

40 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
SOLENO THERAPEUTICS INC
Shares:4.5M
Value:$318.5M
Verona Pharma plc
Shares:1.4M
Value:$91.3M
GERON CORP
Shares:27.2M
Value:$43.3M
Trevi Therapeutics, Inc.
Shares:3.5M
Value:$21.9M
AVADEL PHARMACEUTICALS PLC
Shares:2.7M
Value:$21.0M
Terns Pharmaceuticals, Inc.
Shares:6.9M
Value:$19.0M
Cidara Therapeutics, Inc.
Shares:684.3K
Value:$14.7M
Aclaris Therapeutics, Inc.
Shares:8.9M
Value:$13.6M
Viridian Therapeutics, Inc.\DE
Shares:982.6K
Value:$13.2M
Dyne Therapeutics, Inc.
Shares:1.1M
Value:$11.7M
Oric Pharmaceuticals, Inc.
Shares:2.1M
Value:$11.6M
Instil Bio, Inc.
Shares:585.5K
Value:$10.2M
COMPASS Pathways plc
Shares:3.4M
Value:$9.6M
DELCATH SYSTEMS, INC.
Shares:750.2K
Value:$9.5M
Zenas BioPharma, Inc.
Shares:1.2M
Value:$9.3M
Verastem, Inc.
Shares:1.5M
Value:$9.3M
Erasca, Inc.
Shares:6.8M
Value:$9.3M
10919W405
Shares:251.6K
Value:$9.1M
Tourmaline Bio, Inc.
Shares:591.9K
Value:$9.0M
ABEONA THERAPEUTICS INC.
Shares:1.8M
Value:$8.8M